Salt Lake City, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:

• TD Cowen 46th Annual Healthcare Conference - Monday, March 2, 2026
• Leerink Partners 2026 Global Healthcare Conference - Monday, March 9, 2026
• Jefferies 2026 Biotech on the Beach Summit — Wednesday, March 11, 2026
• KeyBanc 2026 Healthcare Forum — Tuesday, March 17, 2026

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.recursion.com, or connect on X and LinkedIn.

Investor Contact
investor@recursion.com

Media Contact
media@recursion.com

Recursion Pharmaceuticals